- Home
- GLNG vs SPRC Comparison
GLNG vs SPRC Comparison
Compare GLNG & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLNG | SPRC |
|---|---|---|
| Founded | 1946 | 2004 |
| Country | Bermuda | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GLNG | SPRC |
|---|---|---|
| Price | $38.44 | $1.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $49.83 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 554.0K |
| Earning Date | 11-21-2023 | 03-23-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ 333.77 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $326,627,000.00 | $1,306,000.00 |
| Revenue This Year | $50.18 | N/A |
| Revenue Next Year | $0.91 | N/A |
| P/E Ratio | $68.02 | ★ N/A |
| Revenue Growth | 19.15 | ★ 187.98 |
| 52 Week Low | $29.56 | $1.25 |
| 52 Week High | $45.98 | $37.59 |
Technical Indicators
Market Signals| Indicator | GLNG | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 38.75 |
| Support Level | $37.59 | $1.25 |
| Resistance Level | $37.77 | $1.52 |
| Average True Range (ATR) | 0.82 | 0.12 |
| MACD | 0.15 | 0.05 |
| Stochastic Oscillator | 77.51 | 54.35 |
Price Performance
Historical ComparisonAbout GLNG Golar Lng Ltd
Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.